In June 2018, following a lengthy process of research and clinical trials, the FDA approved the use of CBD to treat two rare and severe types of epilepsy that do not respond well to other treatments.
The first new drug approval was for Cloquet, a topical formulation that contains CBD, the non-psychoactive chemical compound found in the marijuana plant. The second new drug approval was for Rizatriptan, a new form of anticonvulsant medicine that contains CBD. If you want to learn more about similar products, learn about about heavy yield seeds here.
The FDA has granted a new marketing authorization for CBD, a derivative of cannabis that is used to treat intractable epilepsy, in a bottle containing 150 mg of the product per daily dose. The new marketing authorization is for children with Lennox-Gastaut syndrome (LGS) and Dravet syndrome (DST) which are rare epilepsy disorders that do not respond well to anticonvulsant drugs. The new drug approval is not for patients with epilepsy on medication. The product does not contain cannabis, or any other ingredients, that are prohibited by the federal Controlled Substances Act.”
So, as you can see, the FDA clearly made a decision to do just that, at least according to the wording of the new labeling. If the federal government wants to classify cannabis as an illegal substance (or something worse than it has ever been), it is free to do so, just as long as it doesn’t do it by regulating anything at all.
The government could be completely and totally wrong, and the cannabis plant could become more widely accepted as a valuable medicine. The FDA should wait until such time as the science on cannabis as medicine is properly studied. It’s clear that the federal government’s decision to keep cannabis illegal is due to the belief that the plant is less harmful than the drugs it’s classified as a controlled substance. It is also clear that they believe that the cannabis plant is less dangerous than alcohol, cigarettes, and other drugs. In fact, the Food and Drug Administration regulates more drugs than marijuana. There’s just no evidence that the FDA or any other regulatory body is a more reliable watchdog than the scientific community.